|
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.Each event reported to bd is evaluated and investigated in accordance with our complaint investigation procedures.The investigation process includes, but is not limited to, evaluation of the event details provided by the complaint facility, a review of complaint history, manufacturing records and risk document where applicable, and an evaluation of the subject device when available to identify potential contributing factors.The device has not been returned to the manufacturer for evaluation.
|
|
It was reported, drug precipitate was observed around the distal end of the pigtail tubing on the needle for most instances; 5-fluorouracil infusing.Patients did not receive their full prescribed dose of chemotherapy, but the amount leaked is unmeasurable, so patients are underdosed on critical medications, localized skin irritation due to hazardous drug exposure.The ports were re-accessed with new needles from other lots, and the problem was not reproduced.A specific number of affected devices or patients was not provided by the complainant.
|